From: Treatment outcome of high-dose image-guided intensity-modulated radiotherapy using intra-prostate fiducial markers for localized prostate cancer at a single institute in Japan
UA
MA
NCCN risk (IR vs. HR)
0.01*
0.96
GS (8–10 vs. < 8)
<0.001*
0.044*
ADT (yes vs. no)
0.1
0.967
ADT duration (continuous)
0.452
0.549
STADT vs. LTADT
0.477
0.513
Pretreatment PSA (≤20 vs. >20)
0.046*
0.29
PLND (yes vs. no)
0.316
0.454